277 related articles for article (PubMed ID: 27036049)
1. REG4 promotes peritoneal metastasis of gastric cancer through GPR37.
Wang H; Hu L; Zang M; Zhang B; Duan Y; Fan Z; Li J; Su L; Yan M; Zhu Z; Liu B; Yang Q
Oncotarget; 2016 May; 7(19):27874-88. PubMed ID: 27036049
[TBL] [Abstract][Full Text] [Related]
2. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
[TBL] [Abstract][Full Text] [Related]
3. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
Mukai S; Oue N; Oshima T; Imai T; Sekino Y; Honma R; Sakamoto N; Sentani K; Kuniyasu H; Egi H; Tanabe K; Yoshida K; Ohdan H; Yasui W
J Pathol; 2017 Sep; 243(1):100-110. PubMed ID: 28671736
[TBL] [Abstract][Full Text] [Related]
6. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways.
Li W; Wang D; Sun X; Zhang Y; Wang L; Suo J
Int J Mol Med; 2019 Feb; 43(2):914-926. PubMed ID: 30569104
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways.
Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z
Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499
[TBL] [Abstract][Full Text] [Related]
8. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
[TBL] [Abstract][Full Text] [Related]
10. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
11. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
[TBL] [Abstract][Full Text] [Related]
12. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
13. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
14. Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer.
Hisamatsu Y; Oki E; Otsu H; Ando K; Saeki H; Tokunaga E; Aishima S; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2016 Jun; 23(6):1986-92. PubMed ID: 26847684
[TBL] [Abstract][Full Text] [Related]
15. VEGF significance in peritoneal recurrence from gastric cancer.
Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
Gastric Cancer; 2005; 8(3):155-63. PubMed ID: 16086118
[TBL] [Abstract][Full Text] [Related]
16. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Hiraki M; Kitajima Y; Koga Y; Tanaka T; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2011 Oct; 18(10):3013-9. PubMed ID: 21409489
[TBL] [Abstract][Full Text] [Related]
17. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of Tensin4 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]